These gifts will be available to you through 31 January 2013
How FDA is Advancing Regulatory Science Through High Quality Collaboration
Dr. Stephen Spielberg, Deputy Commissioner for Medical Products and Tobacco, FDA
This executive-level presentation was one of the highlights of the 2012 ISPE Annual Meeting. Watch the video to hear this top-level FDA official discuss how the FDA is addressing regulatory strategies and international collaboration through its partnerships with organizations like ISPE.
From the 2012 ISPE Annual Meeting
Chapter 1 from the ISPE GAMP® Good Practice Guide: A Risk-Based Approach to GxP Compliant Laboratory Computerized Systems
Download Chapter ( 445 KB)
Recently updated to conform with GAMP® 5 concepts and terminology, as well as recent regulatory and industry developments, this GAMP Good Practice Guide contains steps that scientists, suppliers and others involved in managing laboratory computerized system acquisition, implementation, and operations can use to verify laboratory systems are fit for their intended use.
From the ISPE GAMP Guidance Series
Network with dedicated like-minded professionals.
ISPE offers some of the best networking opportunities in the industry. Whether it's through our extensive international network of Affiliate and Chapters, our discipline-specific Communities of Practice, volunteering on ISPE initiatives or at dedicated networking events at ISPE conferences, ISPE is your gateway to connecting with the top technical minds in your region and all over the world.
If you have feedback regarding your monthly gift from ISPE, including suggestions for future content, please contact Rosemary Jones at firstname.lastname@example.org. Don't forget to review your Member Benefits on a regular basis to stay current and make the most of your membership!
Clinical Labeling of Medicinal Products: EU Clinical Trial Regulation
Tuesday, 03 May 2016 18.05
Design Considerations for WFI Distillation Systems Part 2
Thursday, 28 Apr 2016 18.04
2016 Annual Meeting Honorary Chair, Joseph Jimenez, Novartis
Tuesday, 26 Apr 2016 12.04